Bristol Myers’ stock rallied Wednesday as investors maintained high hopes for Cobenfy as an Alzheimer’s treatment, even ...

Shares of drugmaker Bristol Myers Squibb were up almost 6% as of Wednesday afternoon, despite a delay in a late-stage study ...

Bristol Myers Squibb stock popped Wednesday after the firm delayed a study testing Cobenfy in Alzheimer's disease psychosis.

There was traffic chaos around Bristol this morning as several busy roads were blocked after crashes. One crash involved three cars and another route was blocked after a bus left the road. Areas that ...

Bristol Myers will enroll more patients in its Cobenfy Alzheimer's psychosis study after site irregularities, with ...

The phase 3 comeback story that Bristol Myers Squibb investors were eagerly anticipating is not to be—at least not this year.

Data from the "ADEPT-2" study, which analysts had hoped would arrive before year's end, are now expected sometime in 2026.

Bristol Myers Squibb will enroll more patients in a key Phase 3 trial studying its drug Cobenfy in psychosis associated with Alzheimer's disease.

Police were called to the area of Battle Street at James P. Casey Road around 9:37 p.m. Friday for a report of a vehicle ...

Junell Osborne and Erica Montgomery have been arrested after, police say, they broke into a Bristol apartment on Friday and ...

Ballad Health announced this week that the Bristol Regional Medical Center (BRMC) is the first hospital in its service area ...